Global Health Share Price Today | Stock Price & Global Health Share Screener
As of November 18, 2026, the live Global Health share price (NSE: MEDANTA) is ₹1,436.60 on NSE and ₹1,434.80 on BSE, down 0.53% from the previous close, with shares trading between ₹1,424.00 and ₹1,467.90 in today's trading session, and a 52-week range of ₹961.10–₹1,508.90. Track MEDANTA market value to gauge the company's total market size. Use the Global Health stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Global Health opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹1,196 and net income of ₹142, with EBITDA of ₹281, an operating margin of 21.0% and a profit margin of 11.9%.
Global Health Share Price Chart
Track the current stock price of Global Health with an interactive chart. Analyse MEDANTA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Global Health stock quote in one place.
The quote of ₹1,436.60 sits between the 52-week low of ₹961.10 and the 52-week high of ₹1,508.90, and the latest session moved -0.53% from the previous close.
Global Health Company Profile - Fundamental Screener
Screen Global Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MEDANTA shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Healthcare Services industry, with Naresh Kumar Trehan listed as chairperson or CEO, and it trades under ISIN INE474Q01031.
Business Overview
Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over...more
Company Details
Classification
Identifiers and Leadership
Global Health Balance Sheet Screener
Screen MEDANTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹5,905, up from ₹4,766 in 2025.
Latest statistics put total assets at ₹5,905 and shareholder funds at ₹3,984, with a leverage ratio of 0.26.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
Assets |
|||||||||
| Total Assets | 5,905 | 4,766 | 4,304 | 4,116 | 3,146 | 2,694 | 0 | 2,430 | 1,984 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 3,795 | 2,514 | 2,236 | 2,050 | 1,776 | 1,616 | 0 | 1,194 | 1,094 |
Liabilities |
|||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1,294 | 760 | 781 | 1,115 | 1,110 | 907 | 0 | 839 | 432 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||||||
| Total Equity | 3,984 | 3,388 | 2,906 | 2,428 | 1,616 | 1,382 | 0 | 1,296 | 1,217 |
| Share Capital | 54 | 54 | 54 | 54 | 51 | 50 | 0 | 49 | 81 |
| Reserves & Surplus | 3,908 | 3,333 | 2,852 | 2,375 | 1,565 | 1,300 | 0 | 1,214 | 1,136 |
Global Health Income Statement Screener - Profit & Revenue Analysis
Screen Global Health income statement and profit fundamentals. Analyze MEDANTA quarterly results. Global Health reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹1,196 and net profit was ₹142, equal to earnings per unit of ₹5.36, at an operating margin of 21%.
In that period expenses were ₹915, interest cost ₹27 and tax ₹46. The next period listed, 2026-Jun, shows revenue of ₹1,326 and net profit of ₹157.
| Item | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 1,196 | 1,326 | 1,493 | 954 | 1,051 | 1,135 | 1,143 | 836 | 883 | 975 | 960 | 732 | 795 | 865 | 855 |
| Expenses | 915 | 1,017 | 1,099 | 757 | 784 | 868 | 940 | 629 | 675 | 728 | 706 | 540 | 595 | 631 | 621 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 281 | 309 | 394 | 198 | 267 | 267 | 203 | 207 | 208 | 247 | 254 | 192 | 199 | 234 | 234 |
| Operating Profit % | 21.00% | 22.00% | 25.00% | 19.00% | 24.00% | 21.00% | 16.00% | 22.00% | 22.00% | 24.00% | 25.00% | 24.00% | 24.00% | 25.00% | 26.00% |
| Depreciation | 67 | 69 | 71 | 49 | 45 | 50 | 61 | 46 | 47 | 49 | 49 | 38 | 40 | 43 | 44 |
| Interest | 27 | 27 | 28 | 15 | 14 | 17 | 22 | 18 | 18 | 16 | 16 | 21 | 18 | 20 | 18 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 187 | 213 | 295 | 133 | 208 | 200 | 120 | 143 | 144 | 181 | 189 | 133 | 141 | 171 | 172 |
| Tax | 46 | 56 | 76 | 32 | 49 | 41 | 25 | 16 | 37 | 50 | 46 | 32 | 39 | 45 | 49 |
| Net Profit | 142 | 157 | 219 | 101 | 159 | 158 | 95 | 127 | 106 | 131 | 143 | 101 | 102 | 125 | 124 |
| EPS | 5.36 | 5.91 | 8.21 | 3.77 | 5.92 | 5.89 | 3.54 | 4.74 | 3.96 | 4.87 | 5.32 | 3.77 | 3.80 | 4.66 | 4.61 |
Global Health Cash Flow Screener - Liquidity Fundamentals
Screen MEDANTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹714, and net cash flow was an outflow of ₹103.
Over the same period, investing activities used ₹1,089 and financing activities provided ₹272.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 714 | 624 | 612 | 645 | 311 | 242 | 175 | 166 | 63 | 228 |
| Investing Activities | -1,089 | -721 | -441 | -342 | -421 | -239 | -87 | -249 | -69 | -241 |
Financing and Net Cash | ||||||||||
| Financing Activities | 272 | -97 | -514 | 346 | 160 | -81 | -1 | 97 | 9 | -7 |
| Net Cash Flow | -103 | -194 | -343 | 648 | 50 | -78 | 87 | 14 | 3 | -20 |
Global Health Shareholding Pattern Screener
See Global Health shareholding pattern with promoter, FII, and DII holdings. Check Global Health promoter holding and ownership changes for MEDANTA on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 33.01%, foreign institutions 10.15%, domestic institutions 14.77% and the public 5.88%, spread across 147,390 shareholders.
The shareholder count was 147,390 in 2026-Mar, compared with 140,531 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 33.01% | 33.00% | 33.00% | 33.03% | 33.01% | 33.01% | 33.01% | 33.04% |
Institutional Investors | ||||||||
| FII Holding | 10.15% | 9.46% | 9.91% | 11.76% | 11.54% | 11.40% | 10.53% | 12.09% |
| DII Holding | 14.77% | 16.89% | 17.01% | 11.93% | 12.20% | 12.98% | 14.00% | 10.25% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 5.88% | 5.60% | 5.40% | 6.53% | 6.48% | 6.03% | 5.95% | 7.14% |
| Other Holding | 36.20% | 35.05% | 34.68% | 36.75% | 36.77% | 36.58% | 36.51% | 37.47% |
| Shareholder Count | 147,390 | 140,531 | 135,371 | 154,688 | 156,372 | 155,806 | 151,241 | 166,253 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Global Health. Global Health dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.50 per unit for 2026-March, a yield of 0.03%, compared with ₹0.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.50, ₹0.00 and ₹0.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.50 | 0.03% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Global Health Stock Index Membership - Nifty & Sensex
See which indices include Global Health stock. Check MEDANTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 19 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX BSEIPO.
Complete Index List
Global Health Market Events Screener - Corporate Actions
Get Global Health corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Global Health stock events that may affect MEDANTA share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 3, 2026, with a record date of November 3, 2026.
It is followed by Annual General Meeting dated September 16, 2026 and Dividend dated August 14, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-11-03 | 2026-11-03 | Quarterly Result Announcement | NA | 5.36% |
| 2026-09-16 | 2026-09-16 | Annual General Meeting | NA | -1.01% |
| 2026-08-14 | 2026-08-14 | Dividend | ₹ 0.50 /share | 17.93% |
| 2026-07-30 | 2026-07-30 | Quarterly Result Announcement | NA | 8.78% |
| 2026-05-14 | 2026-05-14 | Quarterly Result Announcement | NA | 2.20% |
| 2026-02-04 | 2026-02-04 | Quarterly Result Announcement | NA | 8.16% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -5.04% |
| 2025-09-19 | 2025-09-19 | Annual General Meeting | NA | 2.14% |
| 2025-08-22 | 2025-08-22 | Dividend | ₹ 0.50 /share | 11.88% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -1.20% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 3.17% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | 4.13% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -3.80% |
| 2024-09-19 | 2024-09-19 | Annual General Meeting | NA | -6.51% |
| 2024-08-03 | 2024-08-03 | Extraordinary General Meeting | NA | -7.46% |
Global Health Competitors Screener - Peer Stocks Comparison
Screen MEDANTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 125,272 | 53.90 | 25,420 | 15.58% | 2,003 | 61.89 |
| Max Healthcare Institute | 100,339 | 71.20 | 8,536 | 18.82% | 1,442 | 76.17 |
| Manipal Health Enterprises | 92,333 | 104.20 | 10,521 | 25.80% | 917 | 60.80 |
| Aster DM Quality Care | 64,325 | 116.10 | 4,769 | 11.25% | 427 | 57.55 |
| Fortis Healthcare | 60,910 | 57.00 | 9,179 | 16.93% | 1,064 | 57.30 |
| Global Health | 38,830 | 62.80 | 4,509 | 19.56% | 554 | 64.64 |
| Narayana Hrudayalaya | 38,984 | 45.00 | 7,996 | 43.43% | 811 | 61.49 |
| Dr. Lal Path Labs | 33,237 | 57.20 | 2,864 | 12.11% | 510 | 54.28 |
| Krishna Institute of Medical Sciences | 32,269 | 163.00 | 3,931 | 28.16% | 242 | 66.73 |
| Syngene International | 17,533 | 95.70 | 3,809 | 2.56% | 317 | 61.78 |
Global Health Company Announcements - News & Reports Screener
Screen MEDANTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated November 18, 2026.
The next most recent announcements are dated November 16, 2026 and November 12, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-11-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-11-16 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-11-12 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-11-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-11-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-11-03 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-11-03 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-11-03 | Announcement Under Regulation 30 Of Listing Regulations. | - |
| 2026-11-03 | Results For The Quarter & Half Year Ended September 30 2026 | - |
| 2026-11-03 | Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing Regulations 2015 | - |
| 2026-11-02 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-11-02 | Announcement under Regulation 30 (LODR)-Meeting Updates | - |
| 2026-10-31 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-10-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-10-23 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-10-22 | Board Meeting Intimation for Board Meeting Intimation For Schedule Of Board Meeting For The Second Quarter & Half Year Ended September 30 2026 Under Regulation 29 Of SEBI (LODR) 2015. | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹1,436.60, within a 52-week range of ₹961.10 to ₹1,508.90. The P/E ratio is 62.80 and the P/B ratio is 8.91, with earnings per unit of ₹20.71. Market capitalisation stands at ₹38,830.46 Cr and the dividend yield is 0.03%. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 9 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.